Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses
The active form of vitamin D 3 (1,25(OH) 2 D 3 ) has a great impact on T cell effector function. Thus, 1,25(OH) 2 D 3 promotes T helper 2 (Th2) and regulatory T (Treg) cell function and concomitantly inhibits Th1 and Th17 cell function. Thus, it is believed that vitamin D exerts anti-inflammatory ef...
Saved in:
Published in | Frontiers in immunology Vol. 12; p. 722806 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
21.09.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2021.722806 |
Cover
Loading…
Summary: | The active form of vitamin D
3
(1,25(OH)
2
D
3
) has a great impact on T cell effector function. Thus, 1,25(OH)
2
D
3
promotes T helper 2 (Th2) and regulatory T (Treg) cell function and concomitantly inhibits Th1 and Th17 cell function. Thus, it is believed that vitamin D exerts anti-inflammatory effects. However, vitamin D binding protein (DBP) strongly binds both 1,25(OH)
2
D
3
and the precursor 25(OH)D
3
, leaving only a minor fraction of vitamin D in the free, bioavailable form. Accordingly, DBP in physiological concentrations would be expected to block the effect of vitamin D on T cells and dendritic cells. In the present study, we show that pro-inflammatory, monocyte-derived M1 macrophages express very high levels of the 25(OH)D-1α-hydroxylase CYP27B1 that enables them to convert 25(OH)D
3
into 1,25(OH)
2
D
3
even in the presence of physiological concentrations of DBP. Co-cultivation of M1 macrophages with T cells allows them to overcome the sequestering of 25(OH)D
3
by DBP and to produce sufficient levels of 1,25(OH)
2
D
3
to affect T cell effector function. This study suggests that in highly inflammatory conditions, M1 macrophages can produce sufficient levels of 1,25(OH)
2
D
3
to modify T cell responses and thereby reduce T cell-mediated inflammation
via
a vitamin D-mediated negative feed-back loop. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors share senior authorship This article was submitted to Antigen Presenting Cell Biology, a section of the journal Frontiers in Immunology Reviewed by: Gabriel Courties, INSERM U1183 Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice Et Immunothérapies (INSERM), France; Antonio Ferrante, South Australia Pathology, Australia Edited by: Elodie Segura, Institut Curie, France |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2021.722806 |